Covered recipient · General Payments record
MELISSA KAY MEDLEY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2023
$1,184.75
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $216.23 | 12 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $69.01 | 4 |
| Novo Nordisk AS | $55.92 | 3 |
| IDORSIA PHARMACEUTICALS US INC | $28.38 | 2 |
| Merck Sharp & Dohme Corporation | $24.67 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $23.64 | 1 |
| Lilly USA, LLC | $14.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $23.64 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000354393 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $14.46 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1038218319 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $13.92 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1038235901 | CMS |
| Lilly USA, LLC | $14.61 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031828193 | CMS |
| Merck Sharp & Dohme LLC | $24.67 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048926579 | CMS |
| Novo Nordisk Inc | $16.41 | 02/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002438713 | CMS |
| Novo Nordisk Inc | $18.48 | 02/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002438725 | CMS |
| Novo Nordisk Inc | $21.03 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002438739 | CMS |
| PFIZER INC. | $14.62 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050266529 | CMS |
| PFIZER INC. | $22.59 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049116529 | CMS |
| PFIZER INC. | $16.82 | 04/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049685699 | CMS |
| PFIZER INC. | $14.98 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049193735 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.